The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic significance of α1,6-fucosyltransferase (α1,6-FT) in non-small cell lung cancers (NSCLCs).
Rio Honma
No relevant relationships to disclose
Ichiro Kinoshita
No relevant relationships to disclose
Eiji Miyoshi
No relevant relationships to disclose
Utano Tomaru
No relevant relationships to disclose
Yoshihiro Matsuno
No relevant relationships to disclose
Yasushi Shimizu
No relevant relationships to disclose
Satoshi Takeuchi
No relevant relationships to disclose
Kichizo Kaga
No relevant relationships to disclose
Naoyuki Taniguchi
No relevant relationships to disclose
Hirotoshi Akita
No relevant relationships to disclose